Of the nine patients who completed the 12-week trial, six of them reduced their daily consumption of cannabis/tobacco joints by 50 percent.
Region: France
Current cannabis use was “consistently associated with smaller waist circumference, lower BMI, and lower risks of … obesity in patients with chronic HCV infection.”
Subjects who consumed cannabis possessed a 59 percent lower risk of central obesity than did those with no history of use.
Researchers concluded, “Cannabis use is associated with a reduced risk of elevated fatty liver index in HIV-HCV co-infected patients.”
"In this meta-analysis, we found that one in six patients suffering from rheumatologic disease actively consumes cannabis."
"Cannabis use was associated with a lower risk of diabetes independently of clinical and socio-behavioral factors."
“This paper reports a fortuitous discovery of positive cannabinoid effects on CIPO symptoms in a patient, leading to significant relief of GI complaints."
Bordeaux, France: Cannabis inhalation is associated with subjective relief from symptoms of restless legs syndrome…
